Skip the Newspaper. Read the most important articles of the day here.
Author: ForumIAS
10 PM Current Affairs Quiz: July 13, 2020
Check your Current Affairs Knowledge Through our 10 PM Quiz!
9 PM Daily Brief – July 13th,2020
Read out 9 PM brief for all your current affairs needs.
7 PM Editorial |Integrating South Asia Through Trade| 13th July 2020
An Analysis on Integrating South Asia through trade !
Punjab farmers find a better way to grow paddy
News: Punjab Farmers are using direct seeding of rice (DSR) technique to grow paddy instead of traditional ‘transplanting’ practice due to labour shortage following an exodus of migrant labourers amid the COVID-19 pandemic. What is the DSR method of rice cultivation? Direct Seeding of Rice (DSR): It refers to the process of establishing a rice… Continue reading Punjab farmers find a better way to grow paddy
[Downloads] Compilation of 10 pm current affairs quiz – July 2020 week 2
Good Evening every one .We are posting Compilation of 10 pm current affairs quiz – July 2020 week 2. Click on the following link to download 10pm Compilation for the month of July, 2020 – 2nd week
Daily Quiz: UPSC Prelims Marathon (History, Art & Culture) – July 13, 2020
Revised History, Art & Culture? Try Our Prelims marathon !
Must Read News Articles I 13th July 2020
Skip the Newspaper. Read the most important articles of the day here.
NITI Aayog’s Atal Innovation Mission launches ATL App
News: NITI Aayog’s Atal Innovation Mission(AIM) has launched the ‘ATL App Development Module’ for school children all across the country. Facts: ATL App Development Module: It is a free online course on app development that aims to hone the skills of school students and transform them from App users to App makers under the Atal… Continue reading NITI Aayog’s Atal Innovation Mission launches ATL App
Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
News: Biocon drug Itolizumab has been approved by the Drugs Controller General of India(DCGI) for treating moderate to severe Covid-19 patients. Facts: Itolizumab: It is a monoclonal antibody drug manufactured by Biocon for the treatment of severe chronic plaque psoriasis. Monoclonal antibodies are lab-made proteins that act like human antibodies in the immune system and… Continue reading Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients

